Novartis Plans Own Probe Into Tainted Japan Clinical Trial Of Valsartan
This article was originally published in PharmAsia News
Executive Summary
Novartis said it, too, would launch an investigation into a clinical test in Japan of its blood-pressure drug Valsartan (amlodipine) said to have involved one of the Swiss firm's employees.